Gamble Jones Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $9.92M | Sell |
37,776
-2,241
| -6% | -$601K | 0.75% | 35 |
|
|
2022
Q3 | $9.02M | Sell |
40,017
-1,082
| -3% | -$262K | 0.73% | 36 |
|
|
2022
Q2 | $10M | Buy |
41,099
+655
| +2% | +$161K | 0.74% | 33 |
|
|
2022
Q1 | $9.78M | Sell |
40,444
-1,382
| -3% | -$318K | 0.61% | 39 |
|
|
2021
Q4 | $9.41M | Sell |
41,826
-1,169
| -3% | -$247K | 0.56% | 40 |
|
|
2021
Q3 | $9.14M | Buy |
42,995
+146
| +0.3% | +$33.6K | 0.6% | 38 |
|
|
2021
Q2 | $10.4M | Sell |
42,849
-3,955
| -8% | -$973K | 0.68% | 34 |
|
|
2021
Q1 | $11.6M | Buy |
46,804
+392
| +0.8% | +$93.5K | 0.78% | 28 |
|
|
2020
Q4 | $10.7M | Buy |
46,412
+1,073
| +2% | +$247K | 0.73% | 32 |
|
|
2020
Q3 | $11.5M | Sell |
45,339
-232
| -0.5% | -$57.5K | 0.84% | 28 |
|
|
2020
Q2 | $10.7M | Sell |
45,571
-873
| -2% | -$199K | 0.86% | 29 |
|
|
2020
Q1 | $9.42M | Buy |
46,444
+782
| +2% | +$171K | 0.87% | 30 |
|
|
2019
Q4 | $11M | Buy |
45,662
+219
| +0.5% | +$48.3K | 0.86% | 32 |
|
|
2019
Q3 | $8.79M | Buy |
45,443
+2,156
| +5% | +$414K | 0.72% | 33 |
|
|
2019
Q2 | $7.98M | Buy |
43,287
+1,789
| +4% | +$320K | 0.68% | 34 |
|
|
2019
Q1 | $7.88M | Buy |
41,498
+1,458
| +4% | +$278K | 0.7% | 34 |
|
|
2018
Q4 | $7.79M | Buy |
40,040
+1,529
| +4% | +$298K | 0.78% | 29 |
|
|
2018
Q3 | $7.98M | Buy |
38,511
+963
| +3% | +$190K | 0.74% | 31 |
|
|
2018
Q2 | $6.93M | Buy |
37,548
+43
| +0.1% | +$7.61K | 0.7% | 34 |
|
|
2018
Q1 | $6.39M | Buy |
37,505
+1,024
| +3% | +$188K | 0.64% | 38 |
|
|
2017
Q4 | $6.34M | Sell |
36,481
-283
| -0.8% | -$50.1K | 0.6% | 37 |
|
|
2017
Q3 | $6.86M | Buy |
36,764
+444
| +1% | +$78.7K | 0.7% | 34 |
|
|
2017
Q2 | $6.25M | Buy |
36,320
+4,424
| +14% | +$720K | 0.66% | 35 |
|
|
2017
Q1 | $5.23M | Buy |
31,896
+12,711
| +66% | +$2.11M | 0.55% | 40 |
|
|
2016
Q4 | $2.81M | Buy |
19,185
+400
| +2% | +$60.2K | 0.31% | 58 |
|
|
2016
Q3 | $3.13M | Sell |
18,785
-54
| -0.3% | -$9.13K | 0.34% | 54 |
|
|
2016
Q2 | $2.87M | Buy |
18,839
+600
| +3% | +$93.3K | 0.31% | 59 |
|
|
2016
Q1 | $2.73M | Sell |
18,239
-225
| -1% | -$33.4K | 0.3% | 63 |
|
|
2015
Q4 | $3M | Buy |
18,464
+1,035
| +6% | +$163K | 0.33% | 55 |
|
|
2015
Q3 | $2.41M | Sell |
17,429
-465
| -3% | -$73.3K | 0.28% | 72 |
|
|
2015
Q2 | $2.75M | Sell |
17,894
-295
| -2% | -$47.3K | 0.29% | 64 |
|
|
2015
Q1 | $2.91M | Sell |
18,189
-300
| -2% | -$47.2K | 0.3% | 61 |
|
|
2014
Q4 | $2.94M | Buy |
18,489
+400
| +2% | +$62.3K | 0.3% | 61 |
|
|
2014
Q3 | $2.54M | Sell |
18,089
-900
| -5% | -$118K | 0.28% | 68 |
|
|
2014
Q2 | $2.25M | Buy |
18,989
+3,975
| +26% | +$460K | 0.25% | 71 |
|
|
2014
Q1 | $1.85M | Sell |
15,014
-10,705
| -42% | -$1.3M | 0.22% | 84 |
|
|
2013
Q4 | $2.93M | Sell |
25,719
-10
| -0% | -$1.14K | 0.35% | 51 |
|
|
2013
Q3 | $2.88M | Sell |
25,729
-5,831
| -18% | -$632K | 0.37% | 49 |
|
|
2013
Q2 | $3.11M | Buy |
+31,560
| New | +$3.28M | 0.41% | 44 |
|
Other funds holding AMGN
AWA
Gamble Jones Investment Counsel's AMGN Position: Q4 2022 in Review
Gamble Jones Investment Counsel reduced its Amgen (AMGN) stake by 5.6% in Q4 2022, selling an estimated $601K and leaving 37,776 shares worth $9.92M. The position accounts for 0.75% of the portfolio, ranked #35.
Gamble Jones Investment Counsel first reported a position in AMGN in Q2 2013 and has held it in 39 quarters since. The position peaked at $11.6M in Q1 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.
- Gamble Jones Investment Counsel held 37,776 shares of Amgen worth $9.92M as of Q4 2022.
- Gamble Jones Investment Counsel sold 2,241 Amgen shares in Q4 2022, an estimated $601K.
- Amgen made up 0.75% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #35 holding.
- Gamble Jones Investment Counsel first reported a position in Amgen in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Amgen position peaked at $11.6M in Q1 2021.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.